# Seaport Therapeutics, Inc. (SPTX) insider trading

> In the 12 months to Nov 19, 2026, 3 SPTX insiders reported open-market purchases of $20.1M across 3 filings; no open-market sales were filed.

Canonical: https://massive.com/quote/sptx/insider-trading
Latest filing: 2026-11-13 (last 12 months; source: SEC EDGAR)
Source: Massive (https://massive.com/docs/llms.txt)

## Summary

| Measure | Value | Detail |
| --- | --- | --- |
| Open-market sales | $0 | 0 filings · 0 insiders |
| Open-market purchases | $20.1M | 3 filings |

## Open-market trades by insider

| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
| --- | --- | --- | --- | --- | --- | --- |
| Kristina Burow | 10% owner | — | $19.8M | 1 | — | 2026-05-04 |
| Robert J. Hombach | Director | — | $235.8K | 1 | — | 2026-06-24 |
| Denice Torres | Director | — | $99.3K | 1 | — | 2026-11-04 |

## Open-market trades by filing

3 filings in the last 12 months, newest first.

| Filed | Traded | Insider | Role | Type | Shares | Avg price | Value | Held after | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 2026-11-04 | 2026-11-03 | Denice Torres | Director | Purchase | 5,000 | $19.87 | $99.3K | 5,000 | — |
| 2026-06-24 | 2026-06-22 | Robert J. Hombach | Director | Purchase | 13,000 | $18.14 | $235.8K | 13,000 | — |
| 2026-05-04 | 2026-05-04 | Kristina Burow | 10% owner | Purchase | 1,100,000 | $18.00 | $19.8M | 6,294,951 | — |

## Other insider activity (not market trades)

- Gifts: 1 record
- Other: 13 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

## How to read this page

- **Open-market purchase or sale**: A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- **Filing date**: Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
- **Counted once**: When several owners (a fund and its partners, say) report the same trade, it's counted once. Corrected filings replace the originals.

## FAQ

### Has Seaport Therapeutics, Inc.'s CEO sold stock?

No. Daphne Zohar (CEO) made no open-market sales filed as CEO in the last 12 months.

### How current is SPTX’s insider data?

These are SPTX Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.

### What counts as an open-market buy or sell?

Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.

## Live data

This page joins two Massive endpoints: Form 4 filings and daily prices. The SPTX Form 4 request:

- `GET https://api.massive.com/stocks/filings/vX/form-4?tickers=SPTX&filing_date.gte=2025-11-19&sort=filing_date.desc&limit=500`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Seaport Therapeutics, Inc. (SPTX) stock price](https://massive.com/quote/sptx.md)
- [Recent insider trading](https://massive.com/quote/insider-trading.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
